Home

Effects of stilbenoid polyphenols (pterostilbene and gnetol) on cardiomyocyte hypertrophy in vitro and in vivo in spontaneously hypertensive heart failure rats

Show simple item record

dc.contributor.supervisor Anderson, Hope (Pharmacy) en_US
dc.contributor.author Akinwumi, Bolanle C.
dc.date.accessioned 2018-04-09T20:41:32Z
dc.date.available 2018-04-09T20:41:32Z
dc.date.issued 2017-02 en_US
dc.date.issued 2018-03 en_US
dc.date.submitted 2018-03-30T14:27:02Z en
dc.identifier.citation Akinwumi BC, Raj P, Lee DI, Acosta C, Yu L, Thomas SM, Nagabhushanam K, Majeed M, Davies NM, Netticadan T and Anderson HD. Disparate Effects of Stilbenoid Polyphenols on Hypertrophic Cardiomyocytes In Vitro vs. in the Spontaneously Hypertensive Heart Failure Rat. Molecules. 2017;22. en_US
dc.identifier.citation Akinwumi BC, Bordun KM and Anderson HD. Biological Activities of Stilbenoids. Int J Mol Sci. 2018;19. en_US
dc.identifier.uri http://hdl.handle.net/1993/32946
dc.description.abstract Cardiac hypertrophy is increase in myocardial mass in response to stress or injury and has been identified as a potential target in the prevention of heart failure. Cardioprotective effects of resveratrol has been widely reported, however low bioavailability limits clinical use. Resveratrol, gnetol (lower bioavailability) and pterostilbene (higher bioavailability) belong to the group of stilbenoid polyphenols. Activation of AMP-activated protein kinase (AMPK), a key energy balance sensor, via phosphorylation at thr-172 is known to be protective and prevent the development of cardiac hypertrophy. Microphthalmia-associated transcription factor (MITF) is a transcription factor involved in melanogenesis. The novel role of MITF in cardiac hypertrophy has been recently identified in the literature. Here I queried first, the anti-hypertrophic effects of gnetol and pterostilbene and the involvement of AMPK and MITF in vitro. Secondly, I examined the cardioprotective effects and the role of bioavailabilities of resveratrol, gnetol and pterostilbene in vivo using spontaneously hypertensive heart failure (SHHF) rats. Effects of gnetol and pterostilbene on ET-1-induced hypertrophy were determined: cell size by immunostaining and computer-assisted planimetry, protein synthesis measured by Click-iT® protein synthesis assay kit and fetal gene (BNP) expression by real time PCR. The role of AMPK was probed using compound C, an AMPK inhibitor and AMPKα1/2 shRNA to knockdown AMPK gene. SHHF and Sprague-Dawley control rats were treated with the stilbenoids (2.5mg/kg/day) by oral gavage. Baseline and endpoint echocardiography were performed to capture cardiac function and heart dimensions. Gnetol inhibited all markers of hypertrophy. Pterostilbene inhibited myocyte size augmentation and protein synthesis but did not prevent fetal gene expression. Gnetol and pterostilbene activated AMPK. Indeed, pre-treatment with compound C and genetic knockdown of AMPK abolished the ability of gnetol and pterostilbene to inhibit myocyte growth. While MITF expression increased in response to ET-1, pre-treatment with stilbenoids prevented ET-1-induced MITF expression. Gnetol and pterostilbene inhibited cardiomyocyte hypertrophy in vitro, at least in part, via AMPK activation. Although the stilbenoids did not prevent left ventricular hypertrophy in SHHF rat, they improved diastolic function to the same extent despite differences in their bioavailabilities. Thus, further studies on mechanisms of cardioprotective effects of stilbenoid polyphenols are warranted. en_US
dc.publisher MDPI en_US
dc.rights info:eu-repo/semantics/openAccess
dc.subject Stilbenoids en_US
dc.subject Cardiac hypertrophy en_US
dc.subject Cardioprotective en_US
dc.subject Heart failure en_US
dc.subject Gnetol en_US
dc.subject Pterostilbene en_US
dc.subject Resveratrol en_US
dc.title Effects of stilbenoid polyphenols (pterostilbene and gnetol) on cardiomyocyte hypertrophy in vitro and in vivo in spontaneously hypertensive heart failure rats en_US
dc.type info:eu-repo/semantics/doctoralThesis
dc.type doctoral thesis en_US
dc.degree.discipline Pharmacy en_US
dc.contributor.examiningcommittee Burczynski, Frank (Pharmacy) Netticadan, Thomas (Physiology and Pathophysiology) Goralski, Kerry (Dalhousie University) en_US
dc.degree.level Doctor of Philosophy (Ph.D.) en_US
dc.description.note May 2018 en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

View Statistics